InvestorsHub Logo

Joseph_K

09/06/23 2:19 PM

#429523 RE: bas2020 #429510

To quote your source,

Manipulative practices tend to be short term and looks to take advantage of the impulsiveness of individual investors.

Personally, I can't wait for this "short term" to be over. I believe a well-executed all-endpoints-met TLR, clearly supported by the kind of statistics serious biotech investors expect, would staunch the bleeding. FDA approval, of course, would kick the share price through the roof.

I'm very long Anavex, but posters like you, whom I see as blindly in love with the stock and incapable or unwilling to recognize real issues, and explain the long term stock price on the ground of "collusive manipulation," are the ones who could scare me into selling!

Okay, I'll let you have the last word in this exchange. I've found it's the only way to avoid rehashing everything interminably. Tell the world I'm a poorly paid message-board manipulator who's out to get them. Have at it! :)